Search for the latest updates on diabetes
News
Transition Therapeutics Diabetes Drug Candidate, TT-401, Commences Phase 2 Clinical Study CNW Group via Yahoo! Finance - 10 minutes
TORONTO , May 15, 2014 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the ...
Manage alerts · Unsubscribe · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Alerts. |
No comments:
Post a Comment